Keifei Pharma - Tesamorelin -Tesamorelinfei Compound Peptide Vial 2mg

Body Composition • Metabolic Support • Fat Reduction Research

Keifei – Tesamorelin (Tesamorelinfei) Compound Peptide Vial 2mg

Keifei Tesamorelinfei 2mg is a premium compounded peptide formulation containing Tesamorelin, a growth hormone–releasing hormone (GHRH) analogue studied in metabolic and body composition research. It is primarily explored for its potential role in supporting healthy fat distribution, particularly visceral fat metabolism, and overall metabolic regulation under professional supervision.

This single-vial format is designed for precision handling, stability, and structured protocol use, making it suitable for targeted wellness and body composition programs.

Key Features & Potential Benefits

GHRH analogue activity (Tesamorelin)
Stimulates natural growth hormone release pathways through pituitary signalling.

Visceral fat reduction research support
Commonly studied for its potential role in reducing abdominal (visceral) fat accumulation.

Body composition support
May assist in improving lean-to-fat ratio when combined with diet and exercise.

Metabolic function support
Involved in pathways that may support lipid metabolism and overall metabolic health.

Growth hormone axis support
Works upstream in the natural growth hormone signalling cascade.

Single-vial format (2mg)
Precision-dosed vial designed for controlled and structured protocol use.

High-purity compounded formulation
Manufactured with a focus on consistency, stability, and controlled peptide handling standards.

Sealed vial integrity
Individually sealed to maintain product stability and reduce contamination risk.